As the HIV research community prepares to convene for the Conference on Retroviruses and Opportunistic Infections (CROI) 2026 ...

UNAIDS welcomes the passing into law by the President of Benin Patrice Talon of Law 2026-02 on 9 February 2026. The law focuses on HIV prevention, management and will accelerate progress towards ...

"You know, an anti-science attitude together with an anti-vaccine attitude is not very good for the public health of the country or the world," Fauci said.

Investigators at the University of Alabama at Birmingham led a study from the ACTG, an NIH-funded global clinical trials network focused on HIV and other infectious diseases, to target the challenges ...

Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making the country one of the first globally to roll it out as the southern African ...

It has taken about two decades, but the world finally has a new, longer-acting injectable drug for HIV prevention. Yesterday, Kenya received 21,000 doses of Lenacapavir, also known as LEN, with about ...

The shift emerged rapidly. In 2021, the country’s two main sexual health hubs, in Suva and Lautoka, did not report a single HIV case transmitted through drug use. Three years later, people injecting ...

Queer Coalition, Illinois State University’s LGBTQIA+ faculty, staff and graduate student affinity group, has begun hosting ...

Kenya will roll out a groundbreaking new HIV-prevention drug in March across 15 priority regions, the health ministry said on Wednesday.

The tiny shell protecting the HIV virus resembles a slightly rounded ice cream cone, but there is nothing sweet about it.

While antiretroviral (ARV) therapies are extending lives and keeping HIV at bay, and PrEP has the potential to effectively ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,* today announced data presentations from its innovative HIV treatment and prevention ...